Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Current Liabilities (2016 - 2021)

Historic Total Current Liabilities for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $1.6 million.

  • ENDRA Life Sciences' Total Current Liabilities rose 1274.08% to $1.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.6 million, marking a year-over-year increase of 1274.08%. This contributed to the annual value of $986663.0 for FY2020, which is 5239.92% down from last year.
  • Per ENDRA Life Sciences' latest filing, its Total Current Liabilities stood at $1.6 million for Q3 2021, which was up 1274.08% from $1.6 million recorded in Q2 2021.
  • Over the past 5 years, ENDRA Life Sciences' Total Current Liabilities peaked at $2.1 million during Q4 2019, and registered a low of $162302.0 during Q2 2017.
  • In the last 5 years, ENDRA Life Sciences' Total Current Liabilities had a median value of $1.3 million in 2020 and averaged $1.2 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 11268.45% in 2019, then crashed by 5239.92% in 2020.
  • ENDRA Life Sciences' Total Current Liabilities (Quarter) stood at $848214.0 in 2017, then rose by 14.9% to $974583.0 in 2018, then soared by 112.68% to $2.1 million in 2019, then tumbled by 52.4% to $986663.0 in 2020, then skyrocketed by 59.81% to $1.6 million in 2021.
  • Its Total Current Liabilities was $1.6 million in Q3 2021, compared to $1.6 million in Q2 2021 and $765825.0 in Q1 2021.